U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C11H16N2O.ClH
Molecular Weight 228.718
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 1-(4-METHOXYPHENYL)PIPERAZINE HYDROCHLORIDE

SMILES

Cl.COC1=CC=C(C=C1)N2CCNCC2

InChI

InChIKey=HFJDUYKRPHHPAX-UHFFFAOYSA-N
InChI=1S/C11H16N2O.ClH/c1-14-11-4-2-10(3-5-11)13-8-6-12-7-9-13;/h2-5,12H,6-9H2,1H3;1H

HIDE SMILES / InChI

Molecular Formula C11H16N2O
Molecular Weight 192.2575
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula ClH
Molecular Weight 36.461
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
38000.0 nM [IC50]
5850.0 nM [IC50]
PubMed

PubMed

TitleDatePubMed
Structure-dependent inhibition of the human α1β2γ2 GABAA receptor by piperazine derivatives: A novel mode of action.
2015-12
Analysis of phenylpiperazine-like stimulants in human hair as trimethylsilyl derivatives by gas chromatography-mass spectrometry.
2010-10-01
4-(4-Methoxy-phen-yl)piperazin-1-ium chloride.
2009-02-11
The effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brain.
2007-03-22
Metabolism of designer drugs of abuse.
2005-06
In vivo metabolism of the new designer drug 1-(4-methoxyphenyl)piperazine (MeOPP) in rat and identification of the human cytochrome P450 enzymes responsible for the major metabolic step.
2004-02
Toxicological detection of the new designer drug 1-(4-methoxyphenyl)piperazine and its metabolites in urine and differentiation from an intake of structurally related medicaments using gas chromatography-mass spectrometry.
2003-12-25
Screening for and validated quantification of amphetamines and of amphetamine- and piperazine-derived designer drugs in human blood plasma by gas chromatography/mass spectrometry.
2003-06
Piperazine-like compounds: a new group of designer drugs-of-abuse on the European market.
2001-09-15
Patents
Substance Class Chemical
Created
by admin
on Mon Mar 31 23:39:35 GMT 2025
Edited
by admin
on Mon Mar 31 23:39:35 GMT 2025
Record UNII
ARJ7BR8SNG
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
1-(4-METHOXYPHENYL)PIPERAZINE HYDROCHLORIDE
Systematic Name English
1-(4-METHOXYPHENYL)PIPERAZINE-1,4-DIYLIUM DICHLORIDE
Preferred Name English
NSC-71661
Code English
1-(PARA-METHOXYPHENYL)PIPERAZINE HYDROCHLORIDE
Systematic Name English
1-(4-METHOXYPHENYL)PIPERAZINE (HYDROCHLORIDE)
Systematic Name English
PIPERAZINE, 1-(4-METHOXYPHENYL)-, MONOHYDROCHLORIDE
Systematic Name English
Code System Code Type Description
PUBCHEM
3019718
Created by admin on Mon Mar 31 23:39:35 GMT 2025 , Edited by admin on Mon Mar 31 23:39:35 GMT 2025
PRIMARY
EPA CompTox
DTXSID401348623
Created by admin on Mon Mar 31 23:39:35 GMT 2025 , Edited by admin on Mon Mar 31 23:39:35 GMT 2025
PRIMARY
FDA UNII
ARJ7BR8SNG
Created by admin on Mon Mar 31 23:39:35 GMT 2025 , Edited by admin on Mon Mar 31 23:39:35 GMT 2025
PRIMARY
NSC
71661
Created by admin on Mon Mar 31 23:39:35 GMT 2025 , Edited by admin on Mon Mar 31 23:39:35 GMT 2025
PRIMARY
ECHA (EC/EINECS)
254-166-6
Created by admin on Mon Mar 31 23:39:35 GMT 2025 , Edited by admin on Mon Mar 31 23:39:35 GMT 2025
PRIMARY
CAS
38869-47-5
Created by admin on Mon Mar 31 23:39:35 GMT 2025 , Edited by admin on Mon Mar 31 23:39:35 GMT 2025
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY